GlassScriptPhysician profile
Thomas M Hulsen
NPI 1417060542
$6,954.92
in general payments reported to CMS, 2019-2025
47 companies · $553 in 2025
The $553 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $949 · 2020: $765 · 2021: $1,379 · 2022: $1,286 · 2023: $1,281 · 2024: $743 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,527 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,526.85 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,131.69 | 2019-2025 | Wegovy |
| Abbvie INC. | $1,080.54 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $691.79 | 2021-2025 | |
| Avion Pharmaceuticals | $588.64 | 2019-2022 | |
| Organon LLC | $481.53 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $219.03 | 2019-2025 | Slynd |
| Takeda Pharmaceuticals U.S.A., INC. | $187.05 | 2019-2022 | |
| Millicent US INC | $181.94 | 2024-2025 | Intrarosa, Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $172.41 | 2019-2025 | |
| Duchesnay USA Incorporated | $152.25 | 2019 | |
| Astellas Pharma US INC | $151.13 | 2021-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $149.47 | 2020-2025 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Pfizer INC. | $139.80 | 2019-2024 | |
| Agile Therapeutics, INC. | $131.34 | 2021-2024 | Twirla |
| Myovant Sciences INC. | $122.06 | 2021-2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hulsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.